Search by Drug Name or NDC
NDC 70710-1158-03 leflunomide 20 mg/1 Details
leflunomide 20 mg/1
leflunomide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is LEFLUNOMIDE.
MedlinePlus Drug Summary
Leflunomide is used alone or in combination with other medications to treat rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function). Leflunomide is in a class of medications called disease-modifying antirheumatic drugs (DMARDs). It works by decreasing inflammation and slowing the progress of the condition, which can help improve the physical activity of people with rheumatoid arthritis.
Related Packages: 70710-1158-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Leflunomide
Product Information
| NDC | 70710-1158 |
|---|---|
| Product ID | 70710-1158_b9ae0559-441f-4be3-88e5-336b2bbfa2b2 |
| Associated GPIs | 66280050000320 |
| GCN Sequence Number | 040550 |
| GCN Sequence Number Description | leflunomide TABLET 20 MG ORAL |
| HIC3 | S2I |
| HIC3 Description | ANTI-INFLAMMATORY, PYRIMIDINE SYNTHESIS INHIBITOR |
| GCN | 67032 |
| HICL Sequence Number | 018694 |
| HICL Sequence Number Description | LEFLUNOMIDE |
| Brand/Generic | Generic |
| Proprietary Name | leflunomide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | leflunomide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | LEFLUNOMIDE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Antirheumatic Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212308 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1158-03 (70710115803)
| NDC Package Code | 70710-1158-3 |
|---|---|
| Billing NDC | 70710115803 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1158-3) |
| Marketing Start Date | 2019-04-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.4172 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | LEFLUNOMIDE 20 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis